Eisaku Nakamura
Direktor/Vorstandsmitglied bei KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Aktive Positionen von Eisaku Nakamura
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direktor/Vorstandsmitglied | 01.03.2016 | - |
| Independent Dir/Board Member | 01.03.2016 | - | |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Direktor/Vorstandsmitglied | 29.03.2018 | - |
| Independent Dir/Board Member | 29.03.2018 | - | |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01.01.2017 | - |
| Direktor/Vorstandsmitglied | 01.09.2013 | 01.01.2017 |
Karriereverlauf von Eisaku Nakamura
Ehemalige bekannte Positionen von Eisaku Nakamura
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACUCELA INC | Direktor/Vorstandsmitglied | 01.05.2015 | - |
Statistik
International
| Japan | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Börse
- Insiders
- Eisaku Nakamura
- Erfahrung
